CMC Development and Manufacturing of Biologics and Biosimilar
The Challenge
The biologics and Biosimilar Organisations are facing the challenges in CMC Strategies for Process and Product development, Analytical Characterisation, Scale up, Tech transfer and Regulatory expectations to make cost effective Biologics and Biosimilar.
Our Approach
Strategic knowledge Partnership from Discovery to Manufacturing including Comprehensive Analytical packages and Regulatory submission and state-of-art Facility design.
Key Outcomes
- Effective CMC Strategies for Process and Product development
- Complete Analytical results with Report as per regulatory expectation
- Mapping of Equipment, resources and Budget planning